Frontlight ResearchEarly access
Colorectal cancer trials in China
616 trials · From ClinicalTrials.gov, checked 15 November 2026. Ask the study team whether a trial fits you.
- No phaseTaking peopleValidation of High-Throughput Large-Format Tissue Preprocessing for Lung and Colorectal Cancer
- Where
- Guangzhou
- People
- 1,000
- Run by
- Nanfang Hospital, Southern Medical University
See details and how to joinNCT07239063 - No phaseTaking peopleAI-Based Prediction of Liver Metastasis in Colorectal Cancer (A Retrospective Study)
- Where
- Wuhan
- Age
- 18 years to 75 years
- People
- 1,500
- Run by
- Tongji Hospital
See details and how to joinNCT07399236 - Phase 2Taking peopleAnlotinib Combined With Sintilimab as First-line Treatment for Advanced Non-liver Metastatic Colorectal Cancer
- Where
- Shanghai
- Age
- 18 years and over
- People
- 37
- Run by
- Shanghai Changzheng Hospital
See details and how to joinNCT07398326 - No phaseTaking peopleProspective Cohort Study on the Relationship Between Exosomal Peroxiredoxin 1 (PRDX1) and Postoperative Liver Metastasis
- Where
- Shanghai
- Age
- 19 months to 80 months
- People
- 260
- Run by
- Mu-qing Yang
See details and how to joinNCT07177742 - Phase 1/2Not yet taking people in ChinaLPM6690176 in Combination With Chemotherapy and Bevacizumab in Metastatic Colorectal Cancer Patients With RAS Mutation
- Where
- Beijing
- Age
- 18 years to 75 years
- People
- 99
- Run by
- Luye Pharma Group Ltd.
See details and how to joinNCT07391566 - Phase 2Taking peopleClinical Study on the First-line Treatment of Advanced Colorectal Cancer With Simultaneous Infusion of Levozolinate for Injection and 5-FU
- Where
- Beijing
- Age
- 18 years to 75 years
- People
- 583
- Run by
- Chinese PLA General Hospital
See details and how to joinNCT07391618 - No phaseTaking peopleProspective Validation of an AI Model for Predicting Liver Metastasis in Colorectal Cancer
- Where
- Wuhan
- Age
- 18 years to 75 years
- People
- 160
- Run by
- Tongji Hospital
See details and how to joinNCT07392567 - No phaseNot yet taking people in ChinaIntegrated Clinical-molecular Risk Stratification to Early Recurrence in Colorectal Liver Metastases
- Where
- Shanghai
- Age
- 18 years to 75 years
- People
- 200
- Run by
- Fudan University
See details and how to joinNCT07391007 - Phase 1Taking peopleA Phase 1 Study of TGI-5 as Monotherapy and in Combination With Nivolumab in Subjects With Locally Advanced/Metastatic Solid Tumors
- Where
- Shanghai
- Age
- 18 years and over
- People
- 194
- Run by
- Hefei TG ImmunoPharma Co., Ltd.
See details and how to joinNCT07376707 - No phaseTaking peopleApplication of Amide Proton Transfer-Weighted Imaging in Predicting Pathological Complete Response After Neoadjuvant Therapy of Rectal Cancer
- Where
- Guangzhou, Maoming
- People
- 320
- Run by
- Sixth Affiliated Hospital, Sun Yat-sen University
See details and how to joinNCT06719414 - No phaseTaking peopleThe Impact of Probiotic Intervention on the Gut Microbiota and Bowel Function
- Where
- Shanghai
- Age
- 18 years to 75 years
- People
- 156
- Run by
- Huashan Hospital
See details and how to joinNCT07369830 - Phase 2Taking peopleComparative Study on the Short- and Long-term Efficacy of Q-ISR, Traditional Sub-ISR, and t-ISR
- Where
- Shanghai
- Age
- 18 years to 75 years
- People
- 100
- Run by
- Fudan University
See details and how to joinNCT07371273 - Phase 3Taking peopleStudy of Perioperative Dostarlimab in Participants With Untreated T4N0 or Stage III dMMR/MSI-H Resectable Colon Cancer
- Where
- Beijing, Changchun, Changsha, Chengdu, Chongqing, Guangzhou, Hangzhou, Harbin, Jinan, Kunming, Meizhou, Nanchang, Shanghai, Shenzhen, Taiyuan, Tianjin, Wuhan, Xiamen, Yangzhou, Zhengzhou
- Age
- 18 years and over
- People
- 892 worldwide
- Run by
- GlaxoSmithKline
See details and how to joinNCT05855200 · EU 2023-503265-27-00 - Phase 1Taking peopleStudy of CEA Targeting CAR-T (PTC13) in the Treatment of CEA-Positive Advanced Malignant Solid Tumors
- Where
- Hangzhou
- Age
- 18 years and over
- People
- 18
- Run by
- Weijia Fang, MD
See details and how to joinNCT06821048 - Phase 1Taking peopleFirst in Human Study of SIM0610 in Solid Tumors
- Where
- Chongqing, Harbin, Jinan, Shanghai, Shenyang
- Age
- 18 years and over
- People
- 260
- Run by
- Jiangsu Simcere Pharmaceutical Co., Ltd.
See details and how to joinNCT07348211 - Phase 2Not yet taking people in ChinaA Study to Explore the Third-line Treatment of Fruquintinib Combined With Serplulimab in Advanced Non-liver-limited Metastatic Colorectal Cancer: a Single-center, Phase 2 Study
- Where
- Shanghai
- Age
- 18 years and over
- People
- 50
- Run by
- Fudan University
See details and how to joinNCT05954429 - Phase 1/2Not yet taking people in ChinaA Phase Ib/II Study to Evaluate HLX43 Combined With HLX07 or Serplulimab in Patients With Advanced or Metastatic Colorectal Cancer
- Where
- Guangzhou
- Age
- 18 years to 75 years
- People
- 126
- Run by
- Shanghai Henlius Biotech
See details and how to joinNCT07358585 - No phaseTaking peopleLeucine Plus Radiochemotherapy for Neoadjuvant Treatment of Locally Advanced Rectal Cancer
- Where
- Hangzhou
- Age
- 18 years to 80 years
- People
- 33
- Run by
- Second Affiliated Hospital, Zhejiang University, School of Medicine
See details and how to joinNCT07359989 - Phase 3Taking peopleA Phase Ib/III Study of Suvemcitug Plus FTD/TPI in Participants With Refractory Metastatic Colorectal Cancer
- Where
- Fuzhou, Hangzhou, Harbin, Jinan, Nanjing, Tianjin
- Age
- 18 years and over
- People
- 464
- Run by
- Jiangsu Simcere Pharmaceutical Co., Ltd.
See details and how to joinNCT07361003 - Phase 2Not yet taking people in ChinaFruquintinib Combined With Trifluridine/Tipiracil Versus Bevacizumab Combined With Trifluridine/Tipiracil for Advanced Metastatic Colorectal Cancer
- Where
- Beijing
- Age
- 18 years to 75 years
- People
- 292
- Run by
- Cancer Institute and Hospital, Chinese Academy of Medical Sciences
See details and how to joinNCT07286695 - Phase 1/2Not yet taking people in ChinaA Study of AK112 in Combination With VG2025 in Colorectal Cancer With Liver Metastases
- Where
- Hangzhou
- Age
- 18 years to 75 years
- People
- 72
- Run by
- Akeso
See details and how to joinNCT07357220 - Phase 1/2Taking peopleA Phase I/IIa Study of JAB-23E73 in Patients With Advanced Solid Tumors Harboring KRAS Gene Alteration
- Where
- Beijing, Changsha, Chengdu, Fuzhou, Guangzhou, Haerbin, Hangzhou, Hefei, Langfang, Nanchang, Nanjing, Nanning, Shanghai, Shenyang, Suzhou, Taiyuan, Tianjin, Wuhan, Xi’an, Zhengzhou
- People
- 334
- Run by
- Jacobio Pharmaceuticals Co., Ltd.
See details and how to joinNCT06959615 - Phase 2Not yet taking people in ChinaPhase Ib/II Study of QL1706 + Fruquintinib + SCRT vs. Standard Third-Line Therapy in Unresectable Liver-Metastatic pMMR/MSS Colorectal Cancer: Safety, Tolerability, and Efficacy.
- Where
- Wuhan
- Age
- 18 years to 75 years
- People
- 76
- Run by
- Tao Zhang
See details and how to joinNCT07353268 - Phase 2Taking peopleA Single-center, Phase II Study on Efficacy & Safety of SCRT+CAPOX+Serplulimab+Bevacizumab for MSS Rectal Cancer
- Where
- Wenzhou
- Age
- 18 years to 75 years
- People
- 30
- Run by
- First Affiliated Hospital of Wenzhou Medical University
See details and how to joinNCT07347951 - Phase 1Taking peopleA Prospective, Safety, and Efficacy Clinical Trial of Pressurized Intraperitoneal Aerosol Therapy for Peritoneal Metastasis of Colorectal Cancer
- Where
- Hangzhou
- Age
- 18 years to 75 years
- People
- 42
- Run by
- Second Affiliated Hospital, Zhejiang University, School of Medicine
See details and how to joinNCT07349043